<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23605689</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1591-9528</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical and experimental medicine</Title><ISOAbbreviation>Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71.</ArticleTitle><Pagination><StartPage>161</StartPage><EndPage>167</EndPage><MedlinePgn>161-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10238-013-0237-6</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) infection can develop devastating clinical outcomes such as brain stem encephalitis (BE) and pulmonary edema (PE). Alteration of human leukocyte antigen-G (HLA-G) expression or cytokine production was considered playing important roles in virus-related pathogenesis. However, clinical relevance of HLA-G in EV71 infection remains unknown. In the current study, patients were stratified by disease severity as BE (n&#xa0;=&#xa0;107) and PE (n&#xa0;=&#xa0;18). HLA-G expression on peripheral blood monocytes from patients with BE (n&#xa0;=&#xa0;15), patients with PE (n&#xa0;=&#xa0;15) and control subjects (n&#xa0;=&#xa0;31) was analyzed with flow cytometry. Plasma soluble HLA-G (sHLA-G) (in 67 BE, 18 PE and 120 control subjects), IL-6 and IL-10 (in 50 patients with BE, 18 patients with PE and 45 control subjects) were determined with enzyme-linked immunosorbent assay. Data showed that the percentage of HLA-G-positive monocytes (mean 7.76 vs 3.68&#xa0;%, p&#xa0;&lt;&#xa0;0.001), levels for sHLA-G (median 129.2 vs 70.6&#xa0;U/ml, p&#xa0;&lt;&#xa0;0.001), IL-10 (median 160.5 vs 29.5&#xa0;pg/ml, p&#xa0;&lt;&#xa0;0.001) and IL-6 (median 20.50 vs 5.21&#xa0;pg/ml, p&#xa0;=&#xa0;0.002) was significantly higher in patients with PE than in patients with BE. Taken together, our findings indicated that elevation of HLA-G expression on monocytes, plasma sHLA-G, IL-10 and IL-6 levels was associated with PE in patients infected with EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiao-Qun</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Department of the Laboratory Medicine, the Second Hospital, Wenzhou Medical College, Wenzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiao-Qing</ForeName><Initials>XQ</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Miao</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Ping</ForeName><Initials>YP</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Dan-Ping</ForeName><Initials>DP</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Aifen</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Wei-Hua</ForeName><Initials>WH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Exp Med</MedlineTA><NlmUniqueID>100973405</NlmUniqueID><ISSNLinking>1591-8890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059951">HLA-G Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059951" MajorTopicYN="N">HLA-G Antigens</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011654" MajorTopicYN="N">Pulmonary Edema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23605689</ArticleId><ArticleId IdType="doi">10.1007/s10238-013-0237-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Infect Dis J. 2009 Oct;28(10):904-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2010 Nov;12(12-13):900-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20673807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2010 Nov;10(11):778-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2011 May;72(5):406-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21377504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2007 Apr;68(4):294-302</Citation><ArticleIdList><ArticleId IdType="pubmed">17400066</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2000 Jun 15;164(12):6426-34</Citation><ArticleIdList><ArticleId IdType="pubmed">10843698</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2009 Aug;9(4):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19570712</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Life Sci. 2011 Feb;68(3):341-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21080028</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2002 Feb 15;16(3):347-51</Citation><ArticleIdList><ArticleId IdType="pubmed">11834945</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Reprod Immunol. 2009 Sep;62(3):139-46</Citation><ArticleIdList><ArticleId IdType="pubmed">19694639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Life Sci. 2011 Feb;68(3):397-404</Citation><ArticleIdList><ArticleId IdType="pubmed">21103908</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2010 Jul;12(7):505-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Biol (Basel). 2008;131:413-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18634503</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2008 Mar;29(3):125-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18249584</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1974 Mar;129(3):304-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2011 Nov;72(11):1068-73</Citation><ArticleIdList><ArticleId IdType="pubmed">21762747</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn J Infect Dis. 2011;64(1):13-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21266750</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Apr;85(7):3067-76</Citation><ArticleIdList><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Neonatol. 2008 Aug;49(4):113-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19054915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2009 Jul;9(7):503-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19498380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2009 Dec;70(12):966-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19664675</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Anti Infect Ther. 2009 Aug;7(6):735-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Feb 1;36(3):269-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Oct 1;198(7):1002-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2003 Aug 15;188(4):564-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Immunol. 2007 Apr;4(2):91-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17484802</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Dec;79(24):15226-37</Citation><ArticleIdList><ArticleId IdType="pubmed">16306594</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2008 Nov;69(11):700-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18817832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2011 Feb;72(2):159-65</Citation><ArticleIdList><ArticleId IdType="pubmed">21087648</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2007 Jul;13(7):677-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17441979</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2009 Jul 17;23(11):1437-40</Citation><ArticleIdList><ArticleId IdType="pubmed">19461504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2000 Nov;61(11):1138-49</Citation><ArticleIdList><ArticleId IdType="pubmed">11137219</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2002;91(6):632-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Metab Immune Disord Drug Targets. 2011 Mar;11(1):76-89</Citation><ArticleIdList><ArticleId IdType="pubmed">21348818</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2009 Sep 1;200(5):820-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19619059</ArticleId></ArticleIdList></Reference><Reference><Citation>J Viral Hepat. 2011 Feb;18(2):102-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20236238</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>